Biotech · Private company
Partner Therapeutics, Inc.
Track this companyFree. Adds Partner Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Abiraterone acetate tabletsPhase 2 · NSCLC Harboring NRG1 FusionClinicalTrials.gov · fetched Nov 12, 2026
- Afatinib Oral TabletPhase 2 · NSCLC Harboring NRG1 FusionClinicalTrials.gov · fetched Nov 12, 2026
- Enzalutamide PillPhase 2 · NSCLC Harboring NRG1 FusionClinicalTrials.gov · fetched Nov 12, 2026
- Ipilimumab-containing therapyPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- MCLA-128Phase 2 · NSCLC Harboring NRG1 FusionClinicalTrials.gov · fetched Nov 12, 2026
- SargramostimPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- SargramostimPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- SargramostimPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- zenocutuzumab (MCLA-128)Phase 2 · Solid Tumours Harboring NRG1 FusionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Sargramostim With Ipilimumab Containing Therapy in Patients With Solid TumorsPHASE2 · WITHDRAWN · started Jan 1, 2024ClinicalTrials.gov NCT05284214 · fetched Nov 12, 2026
- Biomarker Validation Following Sargramostim Treatment in Parkinson's DiseasePHASE1 · COMPLETED · started Jan 19, 2023ClinicalTrials.gov NCT05677633 · fetched Nov 12, 2026
- Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined CancersPHASE2 · TERMINATED · started Nov 17, 2022ClinicalTrials.gov NCT05588609 · fetched Nov 12, 2026
- Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's DiseasePHASE2 · RECRUITING · started Jun 1, 2022ClinicalTrials.gov NCT04902703 · fetched Nov 12, 2026
- A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of ChemoimmunotherapyPHASE2 · TERMINATED · started Jan 3, 2022ClinicalTrials.gov NCT04856176 · fetched Nov 12, 2026
- Sargramostim Use in COVID-19 to Recover Patient HealthPHASE2 · COMPLETED · started Apr 27, 2021ClinicalTrials.gov NCT04707664 · fetched Nov 12, 2026
- Study of Sargramostim in Patients With COVID-19PHASE2 · COMPLETED · started Aug 18, 2020ClinicalTrials.gov NCT04411680 · fetched Nov 12, 2026
- A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 1, 2015ClinicalTrials.gov NCT02912949 · fetched Nov 12, 2026